Mark Schroeder, MD, MSCI

Bone Marrow Transplant Specialist, Medical Oncologist

Mark Schroeder

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108

Expertise & Training

Video thumbnail for Mark Schroeder, MD

Watch video on YouTube

Mark Schroeder, MD

2 mins

Washington University bone marrow transplant specialist and medical oncologist Mark Schroeder, MD, discusses what bone marrow transplant patients can expect from their extended care team at Siteman Cancer Center. Learn more about Dr. Schroeder: https://siteman.wustl.edu/doctor/schroeder-mark/

Explore the Blood and Marrow Transplant Program at Siteman Cancer Center: https://siteman.wustl.edu/treatment/specialized-programs/stem-cell-transplant-and-cellular-therapies-center/blood-and-marrow-transplant-program/

Researchers at Washington University School of Medicine have developed a method for stem cell transplantation that doesn't require radiation or chemotherapy. Learn more: https://siteman.wustl.edu/new-technique-may-lead-to-safer-stem-cell-transplants/

Interested in becoming a donor? Learn more: https://siteman.wustl.edu/treatment/specialized-programs/stem-cell-transplant-and-cellular-therapies-center/blood-and-marrow-transplant-program/for-donors/

Clinical Expertise

Primary Academic Title

Professor of Medicine, Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, WashU Medicine

Board Certification

  • 2009: American Board of Internal Medicine, Medical Oncology
  • 2010: American Board of Internal Medicine, Hematology

Training

  • 2003 - 2004: Intern, Internal Medicine, WashU Medicine, St. Louis, MO
  • 2004 - 2006: Resident, Internal Medicine, WashU Medicine, St. Louis, MO
  • 2006 - 2009: Fellow, Hematology and Oncology, WashU Medicine, St. Louis, MO

Education

  • 2003: MD, University of Cincinnati, Cincinnati, OH
  • 2012: MS, WashU Medicine, St. Louis, MO

Research & Selected Publications

Research Interest

Transplant biology and the development of novel therapeutics and treatment approaches for myelodysplastic syndrome and leukemia. My research in transplant biology includes improving stem cell mobilization and understanding and improving treatment of graft-versus-host disease. My clinical research interest includes hematologic malignancies such as MDS, AML and CLL and their treatment by hematopoietic stem cell transplantation and the development of new treatment approaches.

Research Publications

Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology
Authors:

Kumar SK, Callander NS, Adekola K, one or more additional authors omitted Schroeder MA, one or more additional authors omitted Kumar R

Journal & Year:

J Natl Compr Canc Netw | 2026

Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology
Authors:

Loren AW, Mielcarek M, Bolaños-Meade J, one or more additional authors omitted Schroeder MA, one or more additional authors omitted Stehman K

Journal & Year:

J Natl Compr Canc Netw | 2025

Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT
Authors:

DeFilipp Z, Kim HT, Knight LW, one or more additional authors omitted Schroeder MA, one or more additional authors omitted Hobbs GS

Journal & Year:

Blood | 2025

NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025
Authors:

Kumar SK, Callander NS, Adekola K, one or more additional authors omitted Schroeder MA, one or more additional authors omitted Kumar R

Journal & Year:

J Natl Compr Canc Netw | 2025

Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation
Authors:

Abboud R, Schroeder MA, Rettig MP, one or more additional authors omitted DiPersio JF

Journal & Year:

Blood | 2025

Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Authors:

Kumar SK, Callander NS, Adekola K, one or more additional authors omitted Schroeder MA, one or more additional authors omitted Kumar R

Journal & Year:

J Natl Compr Canc Netw | 2024

Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Authors:

Kumar SK, Callander NS, Adekola K, one or more additional authors omitted Schroeder MA, one or more additional authors omitted Snedeker J

Journal & Year:

J Natl Compr Canc Netw | 2023

Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation
Authors:

Xu Z, Choi J, Cooper M, one or more additional authors omitted Schroeder MA

Journal & Year:

Transplant Cell Ther | 2023